Management of Heart Failure 2019 (4th Edition)
It gives me great pleasure to write a message for another Clinical Practice Guideline (CPG) on the Management of Heart Failure (HF), which is now in its fourth edition. The first CPG in HF was published in 2000 with revisions in 2007 and 2014.
Cardiovascular disease is an important cause of morbidity and mortality in Malaysia. HF, the end stage of most diseases of the heart, is a common medical problem encountered in clinical practice and is an important cause of hospital admissions and readmissions. It is also an important cause of hospital expenditure.
Since the last CPG in 2014 the treatment modalities for the management of HF has expanded extensively. There have been many significant developments in the use of drugs and devices. These guideline-changing data have been incorporated into this CPG, taking into account our local health resources.
A CPG is only successful if it is accepted and implemented. I encourage all healthcare providers involved in the management of HF in children and adults to adopt these recommendations in your practice.
Finally, I would like to congratulate the Chairman and members of the Expert Committee for developing such a comprehensive CPG. Thanks to you, as well as the External Reviewers, for your time and effort.
Datuk Dr. Noor Hisham Bin Abdullah
Director-General of Health Malaysia
Ministry of Health Malaysia
Statement of intent:
This clinical practice guidelines (CPG) is meant to be a guide for clinical practice, based on the best available evidence at the time of development. Adherence to these guidelines may not necessarily guarantee the best outcome in every case. Every healthcare provider is responsible for the management of his/her patient based on the clinical picture presented by the patient and the management options available locally.
Period of validity:
This CPG was issued in 2019 and will be reviewed in 5 years or sooner if new evidence becomes available.
Click on the link below to download full copy in PDF:
